As the market for hip implant procedures continue to expand, the number of defective hip implant lawsuits will probably rise as well.
Collectively, Smith & Nephew, Johnson & Johnson, Stryker, and Zimmer Biomet made over $6.5 billion around the world during 2015. An aging population and an increasing obesity rate may drive global sales as high as $9.1 billion by 2024, according to current market research. Over half these sales will probably be in North America, as patients in the developing world often struggle to afford the procedure and also have a hard time finding qualified doctors to perform the surgery. Increasing per capita income may somewhat alleviate these problems.
According to a new group of studies, testosterone therapy may help some men get stronger bones, but it does almost nothing for sexual problems, anemia, and other issues; furthermore, this treatment plan carries serious health risks that can be fatal.
The much-anticipated TTrials surveyed almost 800 men in twelve different locations nationwide. Many men in the group showed significantly higher bone density levels after receiving aggressive testosterone replacement therapy. Many men also reported having more energy, and some findings did indicate elevated hemoglobin levels in these patients, but some professional reviewers questioned the validity of these findings. The studies found no link between testosterone levels and cognition or sex drive, but researchers found a definite link between testosterone and heart problems.